Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.4M Sell
555,724
-17,496
-3% -$398K 0.1% 321
2026
Q2
$15.8M Buy
573,220
+110,220
+24% +$2.43M 0.13% 270
2026
Q1
$6.77M Buy
463,000
+193,000
+71% +$2.83M 0.07% 417
2025
Q4
$3.41M Buy
+270,000
New +$3.98M 0.03% 521
2025
Q1
– Sell
-53,000
Closed -$1.26M – 855
2024
Q4
$1.26M Buy
53,000
+13,000
+33% +$363K 0.01% 694
2024
Q3
$1.12M Sell
40,000
-4,000
-9% -$113K 0.01% 715
2024
Q2
$1.15M Buy
44,000
+19,000
+76% +$395K 0.01% 699
2024
Q1
$547K Sell
25,000
-5,979
-19% -$128K ﹤0.01% 786
2023
Q4
$721K Sell
30,979
-30,433
-50% -$612K 0.01% 762
2023
Q3
$1.21M Buy
61,412
+28,994
+89% +$571K 0.01% 717
2023
Q2
$735K Buy
+32,418
New +$653K 0.01% 788

Other funds holding RXO

Royce & Associates's RXO Position: Q3 2026 in Review

Royce & Associates reduced its RXO (RXO) stake by 3.1% in Q3 2026, selling an estimated $398K and leaving 555,724 shares worth $11.4M. The position accounts for 0.1% of the portfolio, ranked #321.

Royce & Associates first reported a position in RXO in Q2 2023 and has held it in 11 quarters since. The position peaked at $15.8M in Q2 2026. 206 funds tracked by Wall St. Rank hold RXO as of Q3 2026.

  • Royce & Associates held 555,724 shares of RXO worth $11.4M as of Q3 2026.
  • Royce & Associates sold 17,496 RXO shares in Q3 2026, an estimated $398K.
  • RXO made up 0.1% of Royce & Associates's portfolio in Q3 2026, its #321 holding.
  • Royce & Associates first reported a position in RXO in Q2 2023 and has held it in 11 quarters since.
  • Royce & Associates's RXO position peaked at $15.8M in Q2 2026.
  • 206 funds tracked by Wall St. Rank held RXO as of Q3 2026.

Based on Royce & Associates's 13F filing for Q3 2026, filed 9 Nov 2026.